BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 14605824)

  • 1. Paraneoplastic neurological syndrome: patient with anti-Yo antibody and breast cancer: a case report.
    Dorn C; Knobloch C; Kupka M; Morakkabati-Spitz N; Schmolling J
    Arch Gynecol Obstet; 2003 Nov; 269(1):62-5. PubMed ID: 14605824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive ataxic gait disorder.
    Rupasinghe J; Butler E
    J Clin Neurosci; 2007 Feb; 14(2):153-7. PubMed ID: 17161290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Paraneoplastic cerebellar degeneration--characterization of anti-Yo antibody and underlying cancer].
    Tanaka K; Tanaka M; Onodera O; Tsuji S
    Rinsho Shinkeigaku; 1995 Jul; 35(7):770-4. PubMed ID: 8777801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraneoplastic cerebellar degeneration with anti-Yo antibody in a patient with HER2/neu overexpressing breast cancer: a case report with a current literature review.
    Ogita S; Llaguna OH; Feldman SM; Blum R
    Breast J; 2008; 14(4):382-4. PubMed ID: 18540952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration in a female patient with pleural malignant mesothelioma.
    Tanriverdi O; Meydan N; Barutca S; Ozsan N; Gurel D; Veral A
    Jpn J Clin Oncol; 2013 May; 43(5):563-8. PubMed ID: 23475537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Importance of plasmapheresis in the treatment of paraneoplastic cerebellar degeneration].
    Basić-Jukić N; Kes P; Basić-Kes V; Brunetta B
    Acta Med Croatica; 2004; 58(1):63-6. PubMed ID: 15125396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Paraneoplastic cerebellar degeneration: case report of a patient with breast carcinoma].
    Huober J; Niedermaier N; Drlicek M; Kaufmann M; Hacke W; Bastert G
    Geburtshilfe Frauenheilkd; 1996 Apr; 56(4):214-6. PubMed ID: 8682288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Paraneoplastic cerebellar degeneration associated with ovarian cancer: anti-Yo immunoreactivity in autoptic cerebellum and ovarian carcinoma].
    Bartos A; Stourac P; Rusina R; Sejdová M; Velenská Z
    Nervenarzt; 2002 Oct; 73(10):995-8. PubMed ID: 12376889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Paraneoplastic cerebellar degeneration with bladder cancer confirmed the existence of an anti-neural antibody: a case report].
    Kawanishi K; Morita M; Nakahara K; Tetsuka S; Kouki T; Tominaga K; Endo H; Yashiro T; Tanaka K; Nakano I
    Brain Nerve; 2013 Nov; 65(11):1401-5. PubMed ID: 24200618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Paraneoplastic cerebellar degeneration and Lambert-Eaton myasthenic syndrome associated with anti P/Q-type voltage-gated calcium channel antibody in a patient with primary double lung cancer].
    Iwanami M; Odaka M; Nakamura T; Hirata K
    Brain Nerve; 2009 Sep; 61(9):1083-7. PubMed ID: 19803409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Yo positive paraneoplastic cerebellar degeneration associated with ovarian carcinoma: case report and review of the literature.
    Cao Y; Abbas J; Wu X; Dooley J; van Amburg AL
    Gynecol Oncol; 1999 Oct; 75(1):178-83. PubMed ID: 10502450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraneoplastic cerebellar degeneration in a patient with pseudomyxoma peritonei and breast cancer: case report and literature review.
    Ardavanis A; Sykoutri D; Kountourakis P; Doufexis D; Korkolis D; Tzerbini H; Skarlatos I; Mosa E; Rigatos G
    In Vivo; 2009; 23(5):835-8. PubMed ID: 19779120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraneoplastic cerebellar degeneration mimicking development of secondary progressive multiple sclerosis in a patient with relapsing-remitting multiple sclerosis.
    Gracien R; Kordulla M; Ziemann U
    Mult Scler; 2011 Apr; 17(4):498-500. PubMed ID: 21148018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer revealed by a paraneoplastic cerebellar syndrome: about one case and literature review.
    Adama D; Moussa B; Emmanuel M; Dennis U
    Pan Afr Med J; 2015; 22():25. PubMed ID: 26664526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Subacute paraneoplastic cerebellar degeneration with anti-neuronal antibodies and gynecological cancers. A case report of a bilateral ovarian cancer where the classic "anti-YO" antibody is associated with another antineuronal antibody].
    Tremouilhac C; Hamy A; De Ferron E; Paineau J; Visset J
    J Gynecol Obstet Biol Reprod (Paris); 1996; 25(3):253-6. PubMed ID: 8767221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer.
    Luque FA; Furneaux HM; Ferziger R; Rosenblum MK; Wray SH; Schold SC; Glantz MJ; Jaeckle KA; Biran H; Lesser M
    Ann Neurol; 1991 Mar; 29(3):241-51. PubMed ID: 2042940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration in a man with esophageal adenocarcinoma.
    Xia K; Saltzman JR; Carr-Locke DL
    MedGenMed; 2003 Aug; 5(3):18. PubMed ID: 14600654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Paraneoplastic cerebellar degeneration. A case report].
    Storstein A; Vedeler C; Krossnes B; Mørk S
    Tidsskr Nor Laegeforen; 1997 Aug; 117(20):2947-8. PubMed ID: 9340852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Ri-associated paraneoplastic cerebellar degeneration and breast cancer: an autopsy case study.
    Brieva-Ruíz L; Diaz-Hurtado M; Matias-Guiu X; Márquez-Medina D; Tarragona J; Graus F
    Clin Neurol Neurosurg; 2008 Dec; 110(10):1044-6. PubMed ID: 18701208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paraneoplastic cerebellar degeneration with anti-Yo antibodies and an associated submandibular gland tumor: a case report.
    Imai T; Shinohara K; Uchino K; Okuma H; Maki F; Hiruma K; Ariizumi Y; Yamano Y
    BMC Neurol; 2022 May; 22(1):165. PubMed ID: 35501715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.